Relative risk of neurological signs in siblings of patients with schizophrenia

M. F. Egan, Thomas Hyde, J. B. Bonomo, Venkata Mattay, L. B. Bigelow, T. E. Goldberg, Daniel Weinberger

Research output: Contribution to journalArticle

Abstract

Objective: First-degree relatives of patients with schizophrenia appear to have subtle neurological signs, suggesting that these measures could serve as inter-mediate phenotypes in genetic studies of schizophrenia. The strength of a possible genetic component is unknown, however, leaving it uncertain whether such traits could increase the power to find schizophrenia susceptibility loci. The authors' goal was to investigate the strength of this possible genetic component. Method: They estimated the relative risk of neurological impairments in a large group of siblings of patients with schizophrenia. Two standard neurological scales (the Neurological Evaluation Scale and the Woods Scale) were used to examine 115 patients, 185 of their siblings, and 88 normal comparison subjects. Results: There were significant differences between the siblings of patients with schizophrenia and the normal comparison subjects only on the Woods Scale. Relative risk of neurological impairment was significantly increased in the sibling group, but the significance was weak to moderate. Neurological impairment was not redundant with several other inter-mediate phenotypic measures based on cognitive impairment. Conclusions: These data suggest that neurological signs cluster in patients with schizophrenia and their families and could possibly identify a unique component of genetic variance for risk of schizophrenia. However, the fairly low relative risk and the uncertain pathophysiology of such signs may limit their usefulness.

Original languageEnglish (US)
Pages (from-to)1827-1834
Number of pages8
JournalAmerican Journal of Psychiatry
Volume158
Issue number11
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Siblings
Schizophrenia
Phenotype

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Relative risk of neurological signs in siblings of patients with schizophrenia. / Egan, M. F.; Hyde, Thomas; Bonomo, J. B.; Mattay, Venkata; Bigelow, L. B.; Goldberg, T. E.; Weinberger, Daniel.

In: American Journal of Psychiatry, Vol. 158, No. 11, 2001, p. 1827-1834.

Research output: Contribution to journalArticle

Egan, M. F. ; Hyde, Thomas ; Bonomo, J. B. ; Mattay, Venkata ; Bigelow, L. B. ; Goldberg, T. E. ; Weinberger, Daniel. / Relative risk of neurological signs in siblings of patients with schizophrenia. In: American Journal of Psychiatry. 2001 ; Vol. 158, No. 11. pp. 1827-1834.
@article{70b8807061fa4113b9ab82700bc15fdd,
title = "Relative risk of neurological signs in siblings of patients with schizophrenia",
abstract = "Objective: First-degree relatives of patients with schizophrenia appear to have subtle neurological signs, suggesting that these measures could serve as inter-mediate phenotypes in genetic studies of schizophrenia. The strength of a possible genetic component is unknown, however, leaving it uncertain whether such traits could increase the power to find schizophrenia susceptibility loci. The authors' goal was to investigate the strength of this possible genetic component. Method: They estimated the relative risk of neurological impairments in a large group of siblings of patients with schizophrenia. Two standard neurological scales (the Neurological Evaluation Scale and the Woods Scale) were used to examine 115 patients, 185 of their siblings, and 88 normal comparison subjects. Results: There were significant differences between the siblings of patients with schizophrenia and the normal comparison subjects only on the Woods Scale. Relative risk of neurological impairment was significantly increased in the sibling group, but the significance was weak to moderate. Neurological impairment was not redundant with several other inter-mediate phenotypic measures based on cognitive impairment. Conclusions: These data suggest that neurological signs cluster in patients with schizophrenia and their families and could possibly identify a unique component of genetic variance for risk of schizophrenia. However, the fairly low relative risk and the uncertain pathophysiology of such signs may limit their usefulness.",
author = "Egan, {M. F.} and Thomas Hyde and Bonomo, {J. B.} and Venkata Mattay and Bigelow, {L. B.} and Goldberg, {T. E.} and Daniel Weinberger",
year = "2001",
doi = "10.1176/appi.ajp.158.11.1827",
language = "English (US)",
volume = "158",
pages = "1827--1834",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "11",

}

TY - JOUR

T1 - Relative risk of neurological signs in siblings of patients with schizophrenia

AU - Egan, M. F.

AU - Hyde, Thomas

AU - Bonomo, J. B.

AU - Mattay, Venkata

AU - Bigelow, L. B.

AU - Goldberg, T. E.

AU - Weinberger, Daniel

PY - 2001

Y1 - 2001

N2 - Objective: First-degree relatives of patients with schizophrenia appear to have subtle neurological signs, suggesting that these measures could serve as inter-mediate phenotypes in genetic studies of schizophrenia. The strength of a possible genetic component is unknown, however, leaving it uncertain whether such traits could increase the power to find schizophrenia susceptibility loci. The authors' goal was to investigate the strength of this possible genetic component. Method: They estimated the relative risk of neurological impairments in a large group of siblings of patients with schizophrenia. Two standard neurological scales (the Neurological Evaluation Scale and the Woods Scale) were used to examine 115 patients, 185 of their siblings, and 88 normal comparison subjects. Results: There were significant differences between the siblings of patients with schizophrenia and the normal comparison subjects only on the Woods Scale. Relative risk of neurological impairment was significantly increased in the sibling group, but the significance was weak to moderate. Neurological impairment was not redundant with several other inter-mediate phenotypic measures based on cognitive impairment. Conclusions: These data suggest that neurological signs cluster in patients with schizophrenia and their families and could possibly identify a unique component of genetic variance for risk of schizophrenia. However, the fairly low relative risk and the uncertain pathophysiology of such signs may limit their usefulness.

AB - Objective: First-degree relatives of patients with schizophrenia appear to have subtle neurological signs, suggesting that these measures could serve as inter-mediate phenotypes in genetic studies of schizophrenia. The strength of a possible genetic component is unknown, however, leaving it uncertain whether such traits could increase the power to find schizophrenia susceptibility loci. The authors' goal was to investigate the strength of this possible genetic component. Method: They estimated the relative risk of neurological impairments in a large group of siblings of patients with schizophrenia. Two standard neurological scales (the Neurological Evaluation Scale and the Woods Scale) were used to examine 115 patients, 185 of their siblings, and 88 normal comparison subjects. Results: There were significant differences between the siblings of patients with schizophrenia and the normal comparison subjects only on the Woods Scale. Relative risk of neurological impairment was significantly increased in the sibling group, but the significance was weak to moderate. Neurological impairment was not redundant with several other inter-mediate phenotypic measures based on cognitive impairment. Conclusions: These data suggest that neurological signs cluster in patients with schizophrenia and their families and could possibly identify a unique component of genetic variance for risk of schizophrenia. However, the fairly low relative risk and the uncertain pathophysiology of such signs may limit their usefulness.

UR - http://www.scopus.com/inward/record.url?scp=0035157754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035157754&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.158.11.1827

DO - 10.1176/appi.ajp.158.11.1827

M3 - Article

C2 - 11691688

AN - SCOPUS:0035157754

VL - 158

SP - 1827

EP - 1834

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 11

ER -